e-ISSN: Pending
Negative / Null Result ReportOpen accessNeuroscience· cited by 18

The role of microglia in multiple sclerosis: implications for treatment with Bruton’s tyrosine kinase inhibitors

Patrick Vermersch; Laura Airas; Thomas Berger; Florian Deisenhammer; Nikolaos Grigoriadis; Hans‐Peter Hartung; Melinda Magyari; Veronica Popescu · 2025 · Frontiers in Immunology

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Background: Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system (CNS), characterized by inflammation and neurodegeneration. The pathophysiology of MS, especially its progressive forms, involves various cellular components, including microglia, the primary resident immune cells of the CNS. This review discusses the role of microglia in neuroinflammation, tissue repair, and neural homeostasis, as well as their involvement in MS and explores potential therapeutic strategies targeting microglial function. Methods: A literature search conducted in August 202

Abstract by Patrick Vermersch; Laura Airas; Thomas Berger; Florian Deisenhammer; Nikolaos Grigoriadis; Hans‐Peter Hartung; Melinda Magyari; Veronica Popescu, Frontiers in Immunology (2025) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.3389/fimmu.2025.1495529